Special population study of intranasal testosterone in subjects with allergis rhinitis

Trial Profile

Special population study of intranasal testosterone in subjects with allergis rhinitis

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 May 2012

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions; Pharmacokinetics; Registrational
  • Acronyms AA-DD
  • Most Recent Events

    • 01 May 2012 Final results are expected by the end of quarter two 2012 as reported by Trimel Pharmaceutical Corporation.
    • 01 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top